StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.78−0.09 (-1.85%)

Close on Nov 18, 2026Market cap $789.85MP/E 6.2Yield –

Ironwood Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ironwood Pharmaceuticals's price to sales ratio was 2.0× on Nov 10, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.3× to 5.1×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20262.0×+0.4
2025Dec 31, 20251.6×−0.3
2024Dec 31, 20241.9×−2.3
2023Dec 29, 20234.1×−0.4
2022Dec 30, 20224.5×−0.1
2021Dec 31, 20214.6×+0.0
2020Dec 31, 20204.6×−0.3
2019Dec 31, 20194.8×+2.7
2017Jan 31, 20172.1×−0.1
2016Dec 30, 20162.3×−6.9
2015Dec 31, 20159.1×−37.5
2014Dec 31, 201446.6×+25.3
2013Dec 31, 201321.3×+13.7
2012Dec 31, 20127.6×−16.0
2011Dec 30, 201123.6×+21.4
2010Dec 31, 20102.1×–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?